|
Financial Information Relating to Reportable Segments (Detail) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Segment Reporting Information [Line Items] | ||||
| External sales | $ 84,017 | $ 75,083 | $ 169,685 | $ 150,108 |
| Earnings before income taxes | 36,218 | 37,446 | 75,872 | 75,432 |
|
Reportable Segment
|
||||
| Segment Reporting Information [Line Items] | ||||
| External sales | 84,017 | 75,083 | 169,685 | 150,108 |
| Earnings before income taxes | 38,401 | 39,031 | 80,064 | 78,128 |
|
Reportable Segment | Biotechnology
|
||||
| Segment Reporting Information [Line Items] | ||||
| External sales | 70,557 | 69,628 | 143,747 | 139,131 |
| Earnings before income taxes | 36,618 | 36,883 | 75,996 | 73,877 |
|
Reportable Segment | Clinical Controls
|
||||
| Segment Reporting Information [Line Items] | ||||
| External sales | 13,460 | 5,455 | 25,938 | 10,977 |
| Earnings before income taxes | 1,783 | 2,148 | 4,068 | 4,251 |
|
Unallocated Amount to Segment
|
||||
| Segment Reporting Information [Line Items] | ||||
| Earnings before income taxes | $ (2,183) | $ (1,585) | $ (4,192) | $ (2,696) |